Skip to main navigation Skip to search Skip to main content

A phase I multidose study of dacetuzumab (SGN-40; humanized anti-CD40 monoclonal antibody) in patients with multiple myeloma.

  • Mohamad Hussein
  • , James R. Berenson
  • , Ruben Niesvizky
  • , Nikhil Munshi
  • , Jeffrey Matous
  • , Ronald Sobecks
  • , Kate Harrop
  • , Jonathan G. Drachman
  • , Nancy Whiting
  • Cleveland Clinic
  • Cornell University
  • Veterans Health Administration
  • Rocky Mountain Cancer Center
  • Seattle Genetics
  • Institute for Myeloma & Bone Cancer Research
  • Celgene

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalHaematologica
Volume95
Issue number5
DOIs
StatePublished - May 1 2010
Externally publishedYes

Disciplines

  • Pharmacology
  • Medicine and Health Sciences

Cite this